Cargando…

CARD9 contributes to ovarian cancer cell proliferation, cycle arrest, and cisplatin sensitivity

BACKGROUND: Ovarian cancer recurrence and chemotherapy resistance are still urgent issues, and exploring the mechanisms of metastasis and chemotherapy resistance is beneficial to the development of therapeutic methods. Caspase recruitment domain family member 9 (CARD9) and homeobox B5 (HOXB5) are re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yanming, Wang, Chao, Zhu, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9703781/ https://www.ncbi.nlm.nih.gov/pubmed/36443670 http://dx.doi.org/10.1186/s12860-022-00447-0

Ejemplares similares

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells
por: WANG, YIFEI, et al.
Publicado: (2015)

The cranberry flavonoids PAC DP-9 and quercetin aglycone induce cytotoxicity and cell cycle arrest and increase cisplatin sensitivity in ovarian cancer cells
por: Wang, Yifei, et al.
Publicado: (2022)

Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance
por: Shen, Hong, et al.
Publicado: (2013)

ROS-Induced SIRT2 Upregulation Contributes to Cisplatin Sensitivity in Ovarian Cancer
por: Wang, Wenyu, et al.
Publicado: (2020)

Paris Saponin I Sensitizes Gastric Cancer Cell Lines to Cisplatin via Cell Cycle Arrest and Apoptosis
por: Song, Shuichuan, et al.
Publicado: (2016)

δ‐Tocotrienol sensitizes and re‐sensitizes ovarian cancer cells to cisplatin via induction of G1 phase cell cycle arrest and ROS/MAPK‐mediated apoptosis
por: Fontana, Fabrizio, et al.
Publicado: (2021)

Reduced RBPMS Levels Promote Cell Proliferation and Decrease Cisplatin Sensitivity in Ovarian Cancer Cells
por: Rabelo-Fernández, Robert J., et al.
Publicado: (2022)

Downregulation of SOX9 suppresses breast cancer cell proliferation and migration by regulating apoptosis and cell cycle arrest
por: Wang, Yu-Feng, et al.
Publicado: (2021)

Effects of Hormone Agonists on Sf9 Cells, Proliferation and Cell Cycle Arrest
por: Giraudo, Maeva, et al.
Publicado: (2011)

Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
por: Zaffaroni, N., et al.
Publicado: (1998)

Structures of autoinhibited and polymerized forms of CARD9 reveal mechanisms of CARD9 and CARD11 activation
por: Holliday, Michael J., et al.
Publicado: (2019)

Anti-proliferative activity and cell cycle arrest induced by evodiamine on paclitaxel-sensitive and -resistant human ovarian cancer cells
por: Zhong, Zhang-Feng, et al.
Publicado: (2015)

Inhibition of lysine-specific demethylase 1 prevents proliferation and mediates cisplatin sensitivity in ovarian cancer cells
por: Shao, Genbao, et al.
Publicado: (2018)

Sodium butyrate enhances the cytotoxic effect of cisplatin by abrogating the cisplatin imposed cell cycle arrest
por: Koprinarova, Miglena, et al.
Publicado: (2010)

Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles
por: Xiong, Xunhao, et al.
Publicado: (2014)

Aspirin inhibits tumor progression and enhances cisplatin sensitivity in epithelial ovarian cancer
por: Guo, Jianfeng, et al.
Publicado: (2021)

FOLR1 increases sensitivity to cisplatin treatment in ovarian cancer cells
por: Huang, Ming-ju, et al.
Publicado: (2018)

The terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrest
por: Shirazi Fard, Shahrzad, et al.
Publicado: (2014)

Artesunate sensitizes ovarian cancer cells to cisplatin by downregulating RAD51
por: Wang, Bingliang, et al.
Publicado: (2015)

FOXM1 Modulates Cisplatin Sensitivity by Regulating EXO1 in Ovarian Cancer
por: Zhou, Jinhua, et al.
Publicado: (2014)

Nuclear COMMD1 Is Associated with Cisplatin Sensitivity in Ovarian Cancer
por: Fedoseienko, Alina, et al.
Publicado: (2016)

The Role of CARD9 Deficiency in Neutrophils
por: Sheng, Ruanmei, et al.
Publicado: (2021)

ROS-Induced DCTPP1 Upregulation Contributes to Cisplatin Resistance in Ovarian Cancer
por: Wang, Yu, et al.
Publicado: (2022)

Cytoplasmic p21 is a potential predictor for cisplatin sensitivity in ovarian cancer
por: Xia, Xi, et al.
Publicado: (2011)

HDAC9-mediated epithelial cell cycle arrest in G2/M contributes to kidney fibrosis in male mice
por: Zhang, Yang, et al.
Publicado: (2023)

lncRNAs are novel biomarkers for differentiating between cisplatin-resistant and cisplatin-sensitive ovarian cancer
por: Li, Qing, et al.
Publicado: (2018)

Loss of DAB2IP Contributes to Cell Proliferation and Cisplatin Resistance in Gastric Cancer
por: Wang, Guannan, et al.
Publicado: (2021)

Oncogenic microRNA-181d binding to OGT contributes to resistance of ovarian cancer cells to cisplatin
por: Huang, Wei, et al.
Publicado: (2021)

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells
por: BAO, LINGJIE, et al.
Publicado: (2015)

BNIP3 contributes to cisplatin‐induced apoptosis in ovarian cancer cells
por: Jia, Jinghui, et al.
Publicado: (2020)

COPB2 suppresses cell proliferation and induces cell cycle arrest in human colon cancer by regulating cell cycle-related proteins
por: Wang, Yan, et al.
Publicado: (2018)

Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease
por: Yamamoto-Furusho, Jesús K., et al.
Publicado: (2018)

Metformin combined with p38 MAPK inhibitor improves cisplatin sensitivity in cisplatin-resistant ovarian cancer
por: XIE, YA, et al.
Publicado: (2014)

Inhibitory effect of black tea pigments, theaflavin-3/3′-gallate against cisplatin-resistant ovarian cancer cells by inducing apoptosis and G1 cell cycle arrest
por: Pan, Haibo, et al.
Publicado: (2017)

The Inhibitory Effect of Doxycycline on Cisplatin-Sensitive and -Resistant Epithelial Ovarian Cancer
por: Wu, Wei, et al.
Publicado: (2014)

Silencing of NLRP3 Sensitizes Chemoresistant Ovarian Cancer Cells to Cisplatin
por: Li, Weijia, et al.
Publicado: (2023)

Tripterygium glycosides sensitizes cisplatin chemotherapeutic potency by modulating gut microbiota in epithelial ovarian cancer
por: Zhan, Xinlu, et al.
Publicado: (2023)

NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin
por: Lin, Chao, et al.
Publicado: (2012)

Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway
por: WANG, TIAN, et al.
Publicado: (2014)

Triptolide sensitizes cisplatin-resistant human epithelial ovarian cancer by inhibiting the phosphorylation of AKT
por: Huang, Genhua, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_gv84b52dquq5l5e7f4jphou94v